Related Experiment Video
Updated: Aug 9, 2026
Isolation of Murine Peritoneal Macrophages to Carry Out Gene Expression Analysis Upon Toll-like Receptors Stimulation
Published on: April 29, 2015
A routine source of human peritoneal macrophages
Abstract:
The routine availability of nucleated human cells for experimental use in limited in the absence of venipuncture. In this paper we have demonstrated that macrophages may be harvested routinely from the waste dialysis bags of patients undergoing continuous ambulatory peritoneal dialysis. These cells were identified as macrophages by morphology, adherence, phagocytosis, chemotaxis, non-specific esterase staining and peroxidase staining. Macrophages from patients with end-stage renal disease produced arachidonate cyclo-oxygenase products in a pattern similar to that of ascites macrophages obtained from patients with normal kidney function. Arachidonate metabolism was shown to be manipulatable. Thus, indomethacin blocked synthesis of cyclooxygenase products, and OKY-1581, a specific thromboxane synthase inhibitor, increased the release of prostaglandin E2 and prostacyclin, measured as its stable breakdown product 6-keto-prostaglandin F1, whereas the thromboxane B2 synthesis was effectively inhibited.
Insights
Macrophages can be easily obtained from dialysis waste bags, offering a new source of human immune cells for research. Their arachidonate metabolism can be modulated, showing potential for experimental manipulation.
Area of Science:
- Immunology
- Cell Biology
- Nephrology
Background:
- Limited availability of human nucleated cells for research without invasive procedures like venipuncture.
- Need for accessible and non-invasive methods to obtain immune cells for experimental studies.
Purpose of the Study:
- To establish a method for routine harvesting of macrophages from continuous ambulatory peritoneal dialysis (CAPD) waste bags.
- To characterize these harvested macrophages and investigate their arachidonate metabolism.
- To explore the potential for manipulating arachidonate pathways in these cells.
Main Methods:
- Harvesting macrophages from waste dialysis bags of CAPD patients.
- Cell identification using morphology, adherence, phagocytosis, chemotaxis, non-specific esterase, and peroxidase staining.
- Analysis of arachidonate cyclo-oxygenase products in macrophages from end-stage renal disease patients.
- Pharmacological manipulation of arachidonate metabolism using indomethacin and OKY-1581.
Main Results:
- Macrophages were successfully and routinely harvested from CAPD waste bags.
- Harvested cells exhibited characteristic macrophage markers and functions.
- Macrophages from end-stage renal disease patients produced cyclo-oxygenase products similarly to ascites macrophages.
- Indomethacin inhibited cyclo-oxygenase product synthesis, while OKY-1581 modulated prostaglandin and thromboxane B2 synthesis.
Conclusions:
- Dialysis waste bags provide a valuable, non-invasive source of human macrophages for research.
- These macrophages retain functional characteristics and metabolic pathways relevant to immune responses.
- Arachidonate metabolism in these cells is amenable to experimental manipulation, offering therapeutic research opportunities.
